Equities

Medical System Network Co Ltd

Medical System Network Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)415.00
  • Today's Change6.00 / 1.47%
  • Shares traded30.60k
  • 1 Year change-11.51%
  • Beta1.1740
Data delayed at least 20 minutes, as of Nov 06 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MEDICAL SYSTEM NETWORK Co., Ltd. is mainly engaged in the operation of dispensing pharmacy business. The Company operates in five business segments. The Pharmaceutical Product Network segment involves in ordering system of medicines, development and sale of systems, and support services for securitized receivables. The Dispensing Pharmacy segment operates and manages dispensing pharmacies. The Leasing and Equipment-related Business segment involves in the location development of pharmacies, the rental of buildings for clinics, and the operation of buildings and housing for the elderly. The Food Supply segments provides food service within hospitals and welfare facilities. The Others segment involves in clinical trial support services and visiting nursing services.

  • Revenue in JPY (TTM)117.12bn
  • Net income in JPY1.88bn
  • Incorporated1999
  • Employees3.74k
  • Location
    Medical System Network Co Ltd6F, AKK Bldg.24-3, Kita-Jujo Nishi, Chuo-kuSAPPORO-SHI 060-0010JapanJPN
  • Phone+81 116121069
  • Fax+81 116121068
  • Websitehttps://www.msnw.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4350:TYO since
announced
Transaction
value
PharmaShift Co LtdDeal completed07 Nov 202307 Nov 2023Deal completed-11.51%--
Data delayed at least 20 minutes, as of Nov 06 2024 06:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sophia Holdings Co Ltd8.88bn-9.61m5.06bn193.00--1.4913.060.57-6.53-6.532,548.55725.471.2110.487.5446,003,140.00-0.13072.93-0.21035.0937.6835.07-0.10822.321.5711.170.40460.00-4.1414.77-577.93---12.58--
Hyuga Primary Care Co Ltd8.73bn499.36m8.44bn544.0017.314.7611.760.967167.2967.291,176.42244.811.7929.436.4116,050,780.0010.25--16.41--22.98--5.72--1.0759.520.6145--24.46--15.19------
Healthlead PCL8.13bn344.26m9.89bn484.0028.732.2915.451.220.28020.28026.623.521.335.22147.76--5.649.006.6011.2423.1322.774.235.462.4522.960.2145--7.64---36.84------
Satudora Holdings Co Ltd96.62bn481.00m11.16bn1.11k22.531.196.100.115534.8034.806,987.78656.462.156.8133.4887,282,740.001.100.7972.201.4924.8424.390.51330.36310.463112.170.628742.259.192.45440.2374.56-5.881.39
Medical System Network Co Ltd117.12bn1.88bn12.53bn3.74k6.530.78772.450.10762.6662.663,926.12519.251.7311.0835.1231,283,120.002.802.194.303.3541.6440.831.621.330.570315.090.606423.755.303.2715.5332.12-7.853.71
Dingdang Health Technology Group Ltd104.16bn-4.22bn15.18bn2.51k--0.3654--0.1457-0.1627-0.16274.021.591.575.6143.272,041,874.00-6.53-55.91-9.42-82.5132.3832.74-4.17-35.831.86--0.0766--12.1952.7292.03--13.40--
Sunshine Holdings PLC29.18bn2.32bn17.31bn1.70k7.451.804.880.59319.139.13114.6537.821.333.455.0433,119,650.0014.0512.8727.3423.7430.8729.6910.5810.291.0120.220.27416.937.0319.6597.4947.20-5.6948.41
Charmacy Pharmaceutical Co Ltd95.71bn1.10bn18.96bn834.0017.161.5010.940.19810.52450.524545.436.001.475.494.765,904,141.001.701.798.487.996.916.161.151.240.77142.440.588237.095.472.27-43.252.48-16.010.0027
Kimia Farma Tbk PT97.46bn-16.48bn34.33bn10.71k--0.6683--0.3523-307.59-311.081,817.52957.720.54152.784.36882,472,800.00-11.90-1.82-23.42-3.2224.0535.14-21.98-3.080.4154-3.760.5702--7.933.33-737.71---9.87--
Data as of Nov 06 2024. Currency figures normalised to Medical System Network Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

14.36%Per cent of shares held by top holders
HolderShares% Held
Samarang LLPas of 15 Jun 20231.79m5.85%
Nomura Asset Management Co., Ltd.as of 03 Oct 2024706.80k2.31%
SPARX Asset Management Co., Ltd.as of 24 Jul 2023476.20k1.55%
Dimensional Fund Advisors LPas of 03 Oct 2024417.40k1.36%
Nikko Asset Management Co., Ltd.as of 04 Oct 2024398.10k1.30%
Daiwa Asset Management Co. Ltd.as of 30 Sep 2024340.60k1.11%
Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Oct 2024142.40k0.47%
BlackRock Japan Co. Ltd.as of 03 Oct 202452.10k0.17%
Dimensional Fund Advisors Ltd.as of 03 Oct 202439.99k0.13%
Asset Management One Co., Ltd.as of 03 Oct 202433.80k0.11%
More ▼
Data from 30 Jun 2022 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.